Cryoglobulins are present in about a quarter of patients with hepatitis C.
In some, cryoglobulinemia can become symptomatic or even life-threatening.
Dr. Dammacco and colleagues from Italy summarized evolving therapy for the disorder.
|Cryoglobulinemia can become symptomatic or even life-threatening|
|New England Journal of Medicine|
The researchers also evaluated new therapeutic options that are becoming available.
Dr Dammacco's team concludes, "This study reviews new therapies for cryoglobulinemia in hepatitis C."